Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons

Mutations in SPG11 cause a complicated autosomal recessive form of hereditary spastic paraplegia (HSP). Mechanistically, there are indications for the dysregulation of the GSK3β/βCat signaling pathway in SPG11. In this study, we tested the therapeutic potential of the GSK3β inhibitor, tideglusib, to...

Full description

Bibliographic Details
Main Authors: Tatyana Pozner, Annika Schray, Martin Regensburger, Dieter Chichung Lie, Ursula Schlötzer-Schrehardt, Jürgen Winkler, Soeren Turan, Beate Winner
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-12-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2018.00914/full
_version_ 1831518457319915520
author Tatyana Pozner
Annika Schray
Martin Regensburger
Martin Regensburger
Martin Regensburger
Dieter Chichung Lie
Ursula Schlötzer-Schrehardt
Jürgen Winkler
Jürgen Winkler
Soeren Turan
Soeren Turan
Beate Winner
Beate Winner
author_facet Tatyana Pozner
Annika Schray
Martin Regensburger
Martin Regensburger
Martin Regensburger
Dieter Chichung Lie
Ursula Schlötzer-Schrehardt
Jürgen Winkler
Jürgen Winkler
Soeren Turan
Soeren Turan
Beate Winner
Beate Winner
author_sort Tatyana Pozner
collection DOAJ
description Mutations in SPG11 cause a complicated autosomal recessive form of hereditary spastic paraplegia (HSP). Mechanistically, there are indications for the dysregulation of the GSK3β/βCat signaling pathway in SPG11. In this study, we tested the therapeutic potential of the GSK3β inhibitor, tideglusib, to rescue neurodegeneration associated characteristics in an induced pluripotent stem cells (iPSCs) derived neuronal model from SPG11 patients and matched healthy controls as well as a CRISPR-Cas9 mediated SPG11 knock-out line and respective control. SPG11-iPSC derived cortical neurons, as well as the genome edited neurons exhibited shorter and less complex neurites than controls. Administration of tideglusib to these lines led to the rescue of neuritic impairments. Moreover, the treatment restored increased cell death and ameliorated the membranous inclusions in iPSC derived SPG11 neurons. Our results provide a first evidence for the rescue of neurite pathology in SPG11-HSP by tideglusib. The current lack of disease-modifying treatments for SPG11 and related types of complicated HSP renders tideglusib a candidate compound for future clinical application.
first_indexed 2024-12-12T23:17:19Z
format Article
id doaj.art-aa05080c772d4c9388bcf30d5a7732d8
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-12T23:17:19Z
publishDate 2018-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-aa05080c772d4c9388bcf30d5a7732d82022-12-22T00:08:25ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2018-12-011210.3389/fnins.2018.00914415211Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical NeuronsTatyana Pozner0Annika Schray1Martin Regensburger2Martin Regensburger3Martin Regensburger4Dieter Chichung Lie5Ursula Schlötzer-Schrehardt6Jürgen Winkler7Jürgen Winkler8Soeren Turan9Soeren Turan10Beate Winner11Beate Winner12Department of Stem Cell Biology, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyDepartment of Stem Cell Biology, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyDepartment of Stem Cell Biology, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyDepartment of Neurology, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyDepartment of Molecular Neurology, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyInstitute of Biochemistry, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyDepartment of Ophthalmology, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyDepartment of Molecular Neurology, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyCenter of Rare Diseases Erlangen, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyDepartment of Stem Cell Biology, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyInstitute of Biochemistry, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyDepartment of Stem Cell Biology, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyCenter of Rare Diseases Erlangen, Friedrich–Alexander University Erlangen–Nürnberg, Erlangen, GermanyMutations in SPG11 cause a complicated autosomal recessive form of hereditary spastic paraplegia (HSP). Mechanistically, there are indications for the dysregulation of the GSK3β/βCat signaling pathway in SPG11. In this study, we tested the therapeutic potential of the GSK3β inhibitor, tideglusib, to rescue neurodegeneration associated characteristics in an induced pluripotent stem cells (iPSCs) derived neuronal model from SPG11 patients and matched healthy controls as well as a CRISPR-Cas9 mediated SPG11 knock-out line and respective control. SPG11-iPSC derived cortical neurons, as well as the genome edited neurons exhibited shorter and less complex neurites than controls. Administration of tideglusib to these lines led to the rescue of neuritic impairments. Moreover, the treatment restored increased cell death and ameliorated the membranous inclusions in iPSC derived SPG11 neurons. Our results provide a first evidence for the rescue of neurite pathology in SPG11-HSP by tideglusib. The current lack of disease-modifying treatments for SPG11 and related types of complicated HSP renders tideglusib a candidate compound for future clinical application.https://www.frontiersin.org/article/10.3389/fnins.2018.00914/fullinduced pluripotent stem cellneuronal cultureSPG11tideglusibGSK3β inhibitorhereditary spastic paraplegia
spellingShingle Tatyana Pozner
Annika Schray
Martin Regensburger
Martin Regensburger
Martin Regensburger
Dieter Chichung Lie
Ursula Schlötzer-Schrehardt
Jürgen Winkler
Jürgen Winkler
Soeren Turan
Soeren Turan
Beate Winner
Beate Winner
Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons
Frontiers in Neuroscience
induced pluripotent stem cell
neuronal culture
SPG11
tideglusib
GSK3β inhibitor
hereditary spastic paraplegia
title Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons
title_full Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons
title_fullStr Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons
title_full_unstemmed Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons
title_short Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons
title_sort tideglusib rescues neurite pathology of spg11 ipsc derived cortical neurons
topic induced pluripotent stem cell
neuronal culture
SPG11
tideglusib
GSK3β inhibitor
hereditary spastic paraplegia
url https://www.frontiersin.org/article/10.3389/fnins.2018.00914/full
work_keys_str_mv AT tatyanapozner tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT annikaschray tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT martinregensburger tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT martinregensburger tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT martinregensburger tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT dieterchichunglie tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT ursulaschlotzerschrehardt tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT jurgenwinkler tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT jurgenwinkler tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT soerenturan tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT soerenturan tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT beatewinner tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons
AT beatewinner tideglusibrescuesneuritepathologyofspg11ipscderivedcorticalneurons